Treatment Outcomes With Rituximab in 100 Patients With Neuromyelitis Optica: Influence of FCGR3A Polymorphisms on the Therapeutic Response to Rituximab - Kim, S H; Jeong, I H; Hyun, J W (JAMA Neurol, 2015)
et al.